10 Cambridge spinouts forging a future for our planet
25 Oct 202410 companies taking Cambridge ideas out of the lab and into the real world to address the climate emergency.
10 Cambridge spinouts changing the story of cancer
17 Oct 202410 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.
Building a more sustainable world
19 Sep 2024This longstanding partnership between Cambridge, Arup and the Ove Arup Foundation has made our world safer and more sustainable and changed the way professionals are taught.
Quantum leap
21 Mar 2024Meet the brilliant founder and CEO of Nu Quantum, a Cambridge spinout paving the way for a new era of quantum computing.
Cambridge Enterprise celebrates a year of innovation and economic growth
05 Jul 2023Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements.
Cambridge University’s needle-free coronavirus vaccine begins clinical trials in home city
24 Apr 2023Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against SARS-CoV-2 – the virus that causes COVID-19 – and related coronaviruses.
Talking about a revolution: 25 years of BT and Cambridge
14 Oct 2022Cambridge and BT have been working together for more than 25 years developing new technologies, exploring human behaviour and considering how those two things come together to shape our world.
Powering a green revolution
23 May 2022Dr Giorgia Longobardi, founder and CEO of University spinout Cambridge GaN Devices, is harnessing the extraordinary properties of superconductor gallium nitride to halve the amount of energy we use to power our increasingly digital lives.
Cambridge spin-out aiming to make it easier to find and apply regulations
14 Apr 2022RegGenome, a commercial spin-out from the University of Cambridge, has announced the completion of a $6 million seed funding round.
Deep learning and disease detection
07 Apr 2022Marcel Gehrung, co-founder and CEO of rapidly growing Cambridge biotech company, Cyted, on revolutionising disease diagnostics and the challenges of building a business during a pandemic.
